Healthcare
No Link Between High Potency Cannabis and Mental Illness Says New Medical Study
The Reefer Madness headlines about high potency THC pot and mental illness are not backed up by science
No link between high potency pot and mental illness according to new study
For decades, you’ve been told that cannabis will make you crazy. You’ve been told that if you smoke it – “just one marijuana cigarette”, you’ll become a lazy communist with intentions to jizz through life through a hazy expression of nothingness.
Or you might think you can fly and jump out of a window. Oh wait, wasn’t that LSD?
Irrespective of the drug, if it wasn’t made by our pal Big Pharma, it was demonized – and this continued into modern day. Reefer Madness is still alive and one of the more recent myths that has been pushed exhaustively by the mainstream propaganda machine is that “the more potent the pot, the more dangerous!”
Young people WATCH OUT! This shit is so fire, it’s going to melt your brain…unlike the old stuff that also melted your brain but not as melty as this new stuff.
Boogiddy-boogiddy-boogiddy!
They claim that “Science” definitely knows that cannabis does this and that you don’t need to replicate their studies at all, because the science is settled.
Except, usually when it comes to “settled science”, a little bit of poking would reveal that it isn’t as “settled” as once thought, and that in fact the science could be wrong.
Which is the case we’re seeing with the “high potent pot is more dangerous argument”.
Recent Study Reveals…
A recently published study set out to explore whether there was a direct association between high potency cannabis (characterized by a high concentration of THC, the primary psychoactive compound) and an increased risk of anxiety, depression, psychosis-like symptoms, and cannabis dependence. The study was cross-sectional, involving 410 participants who provided cannabis samples for THC concentration analysis and self-reported their cannabis potency preference.
To simplify the jargon, the research aimed to verify whether people who used stronger cannabis were more likely to experience mental health issues or become dependent on the substance. The results, however, contradict the commonly held belief about the dangers of high potency cannabis.
The findings suggested a slight increase in the risk of cannabis dependence for users who preferred high potency types, but this link became insignificant once the frequency of cannabis use was taken into account. Intriguingly, there was no association found between the THC concentration in cannabis and cannabis dependence.
In terms of mental health outcomes, the study found weak evidence of a small association between cannabis potency and depression and anxiety. But crucially, there was no association between preference for high potency cannabis or the THC concentration in cannabis and psychosis-like symptoms.
In simpler terms, the study showed that users who prefer stronger cannabis might be slightly more likely to develop problematic cannabis use. However, the risk didn’t seem to be significantly influenced by the actual THC concentration in the cannabis. Moreover, the study found little evidence to suggest that stronger cannabis leads to an increased risk of depression, anxiety, or psychosis-like symptoms.
This isn’t to say that there is no evidence. It simply means that there is no causality involved. More importantly, it means that there is no definitive answer and anyone who tells you otherwise are choosing to ignore studies like this.
But let’s explore from a user’s perspective on why there would be little to no increase in mental health related issues or psychosis-like symptoms.
Experienced Users know how to self-regulate
From a user’s perspective, it makes perfect sense why high potency cannabis doesn’t necessarily lead to “more problems.” As an experienced cannabis consumer, I’ve learned to understand my personal threshold and know when I’m “adequately high.” When trying a new extract that packs a punch, the first hit might catch me off guard, but I quickly adapt and approach subsequent hits with more caution and less frequency.
Experienced users, like myself, know that a tiny hit of potent cannabis can provide just the right kind of high. We’ve learned when to consume and when to hold back, ensuring we achieve the desired effects without overindulgence. Having both wax and flower at my disposal has also been instrumental in consuming less overall. Sometimes, a single hit from potent stuff is enough to last me the entire day, while other times, I may nurse a joint throughout my day, depending on my objectives.
This level of understanding and self-regulation is common among experienced consumers. We know how to enjoy the benefits of high potency cannabis without getting overwhelmed. We’ve honed our ability to use it responsibly, optimizing our experience while conserving our supply. It’s all about finding the right balance for each individual, and that comes with experience and knowledge of the products we consume.
As such, the concerns about high potency cannabis causing more mental health issues seem exaggerated from a user’s standpoint. With awareness of our personal limits and the ability to adjust our consumption accordingly, many experienced users find that high potency cannabis can actually enhance the cannabis experience, offering greater efficiency and economy without compromising our well-being. It’s all about finding what works best for us as individuals and using cannabis mindfully and responsibly.
Everything has risk, education is what makes an activity safer
This principle holds true for various aspects of life, including cannabis consumption. While cannabis, like many substances, can have potential dangers if used irresponsibly, I am a strong advocate for proper education and informed decision-making to significantly mitigate these risks. As consenting adults, we are sovereign individuals and owners of our bodies, and I firmly stand for our right to make choices about our well-being, armed with the necessary knowledge.
When it comes to cannabis, responsible use revolves around understanding its effects, dosing, and individual tolerance levels. Education empowers us to make informed decisions about how much or little to consume based on our preferences and health needs.
Just as we trust people to consume alcohol responsibly, I believe a similar protocol should apply to other drugs, including cannabis. With responsible approaches, many individuals, including myself, can enjoy cannabis without facing adverse effects.
Interestingly, data has shown that the combined impact of illegal drugs contributes to fewer deaths and less violence than alcohol, which is legally and widely available. This fact underscores the importance of implementing responsible drug policies and education that focus on harm reduction rather than punitive measures.
Be Mindful in your Consumption
We must always understand that whenever we are consuming psychoactive substances – it should be done mindfully. In fact, most people’s problems stem from “mindlessly engaging” in an activity. This is addiction. When the user is subjected to an automated process that maintains them on an endless loop. Each cycle degrading the individual’s will a bit more.
I know that some people have problems with weed. Most people don’t, however some do. And this is why I’m an advocate for mindful consumption.
Know thyself, this is key to experimenting with any substance. Listen to your body, and learn to self-regulate.
If you do this, you can consume virtually any substance and never get hooked. Or at the very minimal, know which ones don’t work “well” with you and which ones do.
Education News
AIIMS Gorakhpur Reservation Controversy: FIR Alleges Fake OBC Certificate Used Despite ₹80 Lakh Income
A major controversy has emerged at AIIMS Gorakhpur after allegations surfaced that reservation benefits were misused to secure a postgraduate medical seat. A criminal case has been registered against former AIIMS Gorakhpur Executive Director Dr. G.K. Pal and his son, Dr. Oro Prakash Pal, over the alleged use of a forged Other Backward Class (OBC) Non-Creamy Layer certificate for admission to an MD course.
The case has triggered widespread debate within medical and administrative circles, raising serious questions about transparency and oversight in admissions to premier medical institutions.
FIR Filed on Court’s Direction
The First Information Report (FIR) was registered at the AIIMS police station following directions from Chief Judicial Magistrate Tvishi Srivastava. According to the complaint, the alleged offence took place on August 30, 2024, when forged documents were purportedly used to obtain an MD seat under the OBC reservation quota.
Sources indicate that the matter was subsequently brought to the attention of the Union Ministry of Health, prompting internal reviews and administrative action.
Alleged Income Far Above Eligibility Threshold
Central to the allegations is the claim that Dr. G.K. Pal and his wife Parvati Pal have a combined annual income exceeding ₹80 lakh. Under existing reservation rules, families with such income levels are not eligible for OBC Non-Creamy Layer benefits.
Following the emergence of the controversy, Dr. Pal was first removed from his position at AIIMS Gorakhpur and later relieved of responsibilities at AIIMS Patna. He is currently posted at JIPMER Puducherry. With the registration of the FIR, officials suggest that further legal and departmental action may follow, depending on the outcome of the investigation.
Complaint Highlights Systemic Concerns
The complaint was filed by Ashutosh Kumar Mishra, a resident of Divyanagar in the Cantonment area. He alleged that the events related to the case occurred between January and September 2024. The complainant argued that misuse of reservation provisions by individuals in senior positions undermines the integrity of public institutions and erodes trust in the medical education system.
The case has reignited concerns over whether verification mechanisms for reservation certificates are robust enough, particularly in high-stakes admissions.
Impact on Medical Community
The allegations have sent shockwaves through the medical fraternity. Experts believe that if the claims are substantiated, the case could prompt a broader review of admission procedures and lead to stricter scrutiny of category certificates across institutions like AIIMS.
Authorities have stated that all relevant documents will be carefully examined before taking further steps. The outcome of the investigation is expected to have far-reaching implications for accountability and compliance in medical admissions.
Questions Await Answers
As the probe continues, several key issues remain unresolved: whether reservation norms were deliberately violated, how verification processes failed, and whether similar cases may surface in the future. For now, the focus remains on the investigation and its potential consequences.
Business
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Business
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.
The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).
Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.
Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.
That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.
Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.
Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.
A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.
Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/
-
Business3 years agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business2 years agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business2 years agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business3 years agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business2 years agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business3 years agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business3 years agoCan Cannabis Help Seasonal Depression
-
Blogs3 years agoCannabis Art Is Flourishing On Etsy
